Samabriva is a biotechnology company which has developed a disruptive platform .
Samabriva has raised $4.3M in total funding. The most recent round was Series A. The last funding was announced in December 2023.
Samabriva's investors include Meusinvest (Noshaq).
Samabriva is headquartered in Amiens, France.
Samabriva is a biotechnology company which has developed a disruptive platform .
Samabriva is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Samabriva — Funding & Investors." VCBacked, December 12, 2023, https://www.vcbacked.co/company/samabriva. Accessed August 22, 2026.
VCBacked. (2023). Samabriva — Funding & Investors. Retrieved August 22, 2026, from https://www.vcbacked.co/company/samabriva
{{cite web |title=Samabriva — Funding & Investors |url=https://www.vcbacked.co/company/samabriva |website=VCBacked |access-date=August 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated